Quotient Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$504K Sell
20,928
-1,575
-7% -$41.2K 0.01% 211
2026
Q1
$632K Buy
22,503
+1,251
+6% +$33.3K 0.02% 164
2025
Q4
$529K Buy
21,252
+3,051
+17% +$76.9K 0.01% 188
2025
Q3
$464K Buy
18,201
+3,015
+20% +$74.4K 0.01% 205
2025
Q2
$368K Buy
15,186
+3,018
+25% +$70.4K 0.01% 235
2025
Q1
$308K Buy
12,168
+3,612
+42% +$94.5K 0.01% 254
2024
Q4
$227K Sell
8,556
-1,711
-17% -$46.4K 0.01% 296
2024
Q3
$297K Buy
10,267
+2,172
+27% +$63.4K 0.01% 251
2024
Q2
$226K Sell
8,095
-842
-9% -$23.2K 0.01% 286
2024
Q1
$248K Sell
8,937
-5,743
-39% -$159K 0.01% 260
2023
Q4
$423K Buy
+14,680
New +$444K 0.02% 190

Other funds holding PFE

Quotient Wealth Partners's PFE Position: Q2 2026 in Review

Quotient Wealth Partners reduced its Pfizer (PFE) stake by 7% in Q2 2026, selling an estimated $41.2K and leaving 20,928 shares worth $504K. The position accounts for 0.01% of the portfolio, ranked #211.

Quotient Wealth Partners first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $632K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Quotient Wealth Partners held 20,928 shares of Pfizer worth $504K as of Q2 2026.
  • Quotient Wealth Partners sold 1,575 Pfizer shares in Q2 2026, an estimated $41.2K.
  • Pfizer made up 0.01% of Quotient Wealth Partners's portfolio in Q2 2026, its #211 holding.
  • Quotient Wealth Partners first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Quotient Wealth Partners's Pfizer position peaked at $632K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.